Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1969 Sep;48(9):1733–1739. doi: 10.1172/JCI106139

Abnormal regulation of adenosine 3′,5′-monophosphate and corticosterone formation in an adrenocortical carcinoma

R L Ney 1,2,3, N J Hochella 1,2,3, D G Grahame-Smith 1,2,3, R N Dexter 1,2,3, R W Butcher 1,2,3
PMCID: PMC535745  PMID: 4390412

Abstract

A spontaneously occurring rat adrenocortical carcinoma which produces corticosterone was maintained by transplantation. The carcinoma appeared to utilize corticosterone biosynthetic steps similar to those of the normal adrenal, but the tumor produced only about 1-10% as much corticosterone per unit tissue weight as nontumorous adrenal glands. The tumor demonstrated little or no increase in corticosterone production in response to adrenocorticotropic hormone (ACTH) either in vivo or in vitro.

In normal adrenals, ACTH increases the activity of adenyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to adenosine-3′,5′-monophosphate (cyclic AMP), the latter then serving as an intracellular regulator of steroidogenesis. ACTH failed to increase cyclic AMP levels in the tumor in vivo or in slices in vitro, conditions under which there were 50- and 20-fold increases in nontumorous adrenals. However, in homogenates fortified with exogenous ATP, adenyl cyclase activity was comparable in the tumor and adrenals, and cyclic AMP formation was increased 3-fold by ACTH in each. As measured in homogenates, the tumor did not possess a greater ability to destroy cyclic AMP than did normal adrenals. Although ATP levels in the carcinoma were found to be considerably lower than those in normal adrenals, it was not clear that this finding can explain the inability of ACTH to increase cyclic AMP levels in intact tumor cells.

While the failure to normally influence cyclic AMP levels in the carcinoma cells could be an important factor in the lack of a steroid response to ACTH, several lines of evidence suggest that the tumor possesses one or more additional abnormalities in the regulation of steroidogenesis. First, in the absence of ACTH stimulation, the tissue concentrations of cyclic AMP were comparable in the tumor and in nontumorous adrenals, but these cyclic AMP levels were associated with a lower level of steroidogenesis in the tumor. Second, tumor slices failed to increase corticosterone production when incubated with cyclic AMP, in contrast to 5-fold increases observed with nontumorous adrenals.

Full text

PDF
1733

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUTCHER R. W., SUTHERLAND E. W. Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine. J Biol Chem. 1962 Apr;237:1244–1250. [PubMed] [Google Scholar]
  2. Butcher R. W., Ho R. J., Meng H. C., Sutherland E. W. Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J Biol Chem. 1965 Nov;240(11):4515–4523. [PubMed] [Google Scholar]
  3. Dexter R. N., Fishman L. M., Ney R. L., Liddle G. W. Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab. 1967 Apr;27(4):473–480. doi: 10.1210/jcem-27-4-473. [DOI] [PubMed] [Google Scholar]
  4. Grahame-Smith D. G., Butcher R. W., Ney R. L., Sutherland E. W. Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex. J Biol Chem. 1967 Dec 10;242(23):5535–5541. [PubMed] [Google Scholar]
  5. HAYNES R. C., Jr, KORITZ S. B., PERON F. G. Influence of adenosine 3',5'-monophosphate on corticoid production by rat adrenal glands. J Biol Chem. 1959 Jun;234(6):1421–1423. [PubMed] [Google Scholar]
  6. HAYNES R. C., Jr The activation of adrenal phosphorylase by the adrenocorticotropic hormone. J Biol Chem. 1958 Nov;233(5):1220–1222. [PubMed] [Google Scholar]
  7. JOHNSON D. F., SNELL K. C., FRANCOIS D., HEFTMANN E. In vitro metabolism of progesterone-4-C-14 in an adrenocortical carcinoma of the rat. Acta Endocrinol (Copenh) 1961 Jul;37:329–335. doi: 10.1530/acta.0.0370329. [DOI] [PubMed] [Google Scholar]
  8. KORITZ S. B., PERON F. G. Studies on the mode of action of the adrenocorticotropic hormone. J Biol Chem. 1958 Jan;230(1):343–352. [PubMed] [Google Scholar]
  9. LIPSETT M. B., HERTZ R., ROSS G. T. CLINICAL AND PATHOPHYSIOLOGIC ASPECTS OF ADRENOCORTICAL CARCINOMA. Am J Med. 1963 Sep;35:374–383. doi: 10.1016/0002-9343(63)90179-7. [DOI] [PubMed] [Google Scholar]
  10. LOSSOW W. J., SHYAMALA G., SHAH S., CHAIKOFF I. L. UPTAKE, HYDROLYSIS AND SYNTHESIS OF CHOLESTEROL ESTERS BY A TRANSPLANTABLE ADRENAL CORTICAL TUMOR. Proc Soc Exp Biol Med. 1965 May;119:126–131. doi: 10.3181/00379727-119-30116. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., PASSONNEAU J. V., HASSELBERGER F. X., SCHULZ D. W. EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. J Biol Chem. 1964 Jan;239:18–30. [PubMed] [Google Scholar]
  12. Ney R. L., Dexter R. N., Davis W. W., Garren L. D. A study of mechanisms by which adrenocorticotropic hormone maintains adrenal steroidogenic responsiveness. J Clin Invest. 1967 Dec;46(12):1916–1924. doi: 10.1172/JCI105681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. RALL T. W., SUTHERLAND E. W. Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem. 1958 Jun;232(2):1065–1076. [PubMed] [Google Scholar]
  14. SILBER R. H., BUSCH R. D., OSLAPAS R. Practical procedure for estimation of corticosterone or hydrocortisone. Clin Chem. 1958 Aug;4(4):278–285. [PubMed] [Google Scholar]
  15. SNELL K. C., STEWART H. L. Variations in histologic pattern and functional effects of a transplantable adrenal cortical carcinoma in intact, hypophysectomized, and newborn rats. J Natl Cancer Inst. 1959 Jun;22(6):1119–1155. [PubMed] [Google Scholar]
  16. SPERRY W. M., WEBB M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J Biol Chem. 1950 Nov;187(1):97–106. [PubMed] [Google Scholar]
  17. Schteingart D. E., Cash R., Conn J. W. Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome. JAMA. 1966 Nov 28;198(9):1007–1010. [PubMed] [Google Scholar]
  18. Vinson G. P. Pathways of corticosteroid biosynthesis from pregnenolone and progesterone in rat adrenal glands. J Endocrinol. 1966 Mar;34(3):355–363. doi: 10.1677/joe.0.0340355. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES